Join to View Full Profile
43 New Scotland Ave# MC-13Albany, NY 12208
Phone+1 518-262-6696
Fax+1 518-373-3931
Dr. Zackon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1992 - 1994
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1990 - 1992
McGill University Faculty Medicine HospitalInternal Medicine, 1986 - 1989
McGill University Faculty of MedicineClass of 1986
Certifications & Licensure
NY State Medical License 1997 - 2026
IL State Medical License 1992 - 1996
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2012 Feb 01
- Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation Start of enrollment: 2018 Jan 01
Publications & Presentations
PubMed
- Shared Local Oncology Care After Allogeneic Hematopoietic Cell Transplantation: A Randomized Clinical Trial.Gregory A Abel, Haesook T Kim, Ira Zackon, Edwin T Alyea, Alexandra S Bailey
JAMA Oncology. 2025-03-01 - Characteristics, blood counts, treatments, and clinical outcomes of 5871 patients with polycythemia vera treated in US community practices.Roger M Lyons, Kathleen M Aguilar, Lavanya Sudharshan, Divea Venkatasetty, Juliet Ndukum
Current Medical Research and Opinion. 2025-01-01 - Nonspecific Signs and/or Symptoms of Cancer: A Retrospective, Observational Analysis from a Secondary Care, US Community Oncology Dataset.Christopher B Benton, Ding He, Karen Todoroff, Marie V Coignet, Ying Luan
Current Oncology. 2024-06-25
Journal Articles
- A Phase 1/2 Study of Evofosfamide, A Hypoxia-Activated Prodrug with or Without Bortezomib in Subjects with Relapsed/Refractory Multiple MyelomaNoopur S Raje, Ira Zackon, Clinical Cancer Research
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
